(2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide

C93H117F2N23O13S6 — CID 159538507

IUPAC(2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide
SMILESCC(=O)CC(C(=O)N1CCN(c2ccc(S(=O)(=O)Nc3ccncn3)cc2)CC1)c1ccccc1.CC(Nc1ccccc1NN)C(=O)N1CCN(c2ccc(S(=O)(=O)Nc3ccncn3)cc2)CC1.C[C@H](C(=O)NC1CCN(c2ccc(S(=O)(=O)Nc3ncns3)cc2)CC1)n1ccc2c(F)cccc21.O=C1[C@@H](NCCc2ccccc2F)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C25H27N5O4S.C24H25FN6O3S2.C23H28N8O3S.C21H21FN4O3S2.8H2/c1-19(31)17-23(20-5-3-2-4-6-20)25(32)30-15-13-29(14-16-30)21-7-9-22(10-8-21)35(33,34)28-24-11-12-26-18-27-24;1-16(31-14-11-20-21(25)3-2-4-22(20)31)23(32)28-17-9-12-30(13-10-17)18-5-7-19(8-6-18)36(33,34)29-24-26-15-27-35-24;1-17(27-20-4-2-3-5-21(20)28-24)23(32)31-14-12-30(13-15-31)18-6-8-19(9-7-18)35(33,34)29-22-10-11-25-16-26-22;22-18-4-2-1-3-15(18)9-11-23-19-10-13-26(20(19)27)16-5-7-17(8-6-16)31(28,29)25-21-24-12-14-30-21;;;;;;;;/h2-12,18,23H,13-17H2,1H3,(H,26,27,28);2-8,11,14-17H,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29);2-11,16-17,27-28H,12-15,24H2,1H3,(H,25,26,29);1-8,12,14,19,23H,9-11,13H2,(H,24,25);8*1H/t;16-;;19-;;;;;;;;/m.1.0......../s1
InChIKeyMDXAHCJGEHPMJY-UIDJTZLVSA-N
MW1995.50 g/mol
LogP13.17
Rot. Bonds31

About (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide

(2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide (PubChem CID 159538507) has the molecular formula C93H117F2N23O13S6 and a molecular weight of 1995.50 g/mol. Its IUPAC name is (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide.

Molecular Properties

Compound Name(2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide
PubChem CID159538507
Molecular FormulaC93H117F2N23O13S6
Molecular Weight1995.50 g/mol
Exact Mass1993.75
IUPAC Name(2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide
SMILESCC(=O)CC(C(=O)N1CCN(c2ccc(S(=O)(=O)Nc3ccncn3)cc2)CC1)c1ccccc1.CC(Nc1ccccc1NN)C(=O)N1CCN(c2ccc(S(=O)(=O)Nc3ccncn3)cc2)CC1.C[C@H](C(=O)NC1CCN(c2ccc(S(=O)(=O)Nc3ncns3)cc2)CC1)n1ccc2c(F)cccc21.O=C1[C@@H](NCCc2ccccc2F)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C25H27N5O4S.C24H25FN6O3S2.C23H28N8O3S.C21H21FN4O3S2.8H2/c1-19(31)17-23(20-5-3-2-4-6-20)25(32)30-15-13-29(14-16-30)21-7-9-22(10-8-21)35(33,34)28-24-11-12-26-18-27-24;1-16(31-14-11-20-21(25)3-2-4-22(20)31)23(32)28-17-9-12-30(13-10-17)18-5-7-19(8-6-18)36(33,34)29-24-26-15-27-35-24;1-17(27-20-4-2-3-5-21(20)28-24)23(32)31-14-12-30(13-15-31)18-6-8-19(9-7-18)35(33,34)29-22-10-11-25-16-26-22;22-18-4-2-1-3-15(18)9-11-23-19-10-13-26(20(19)27)16-5-7-17(8-6-16)31(28,29)25-21-24-12-14-30-21;;;;;;;;/h2-12,18,23H,13-17H2,1H3,(H,26,27,28);2-8,11,14-17H,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29);2-11,16-17,27-28H,12-15,24H2,1H3,(H,25,26,29);1-8,12,14,19,23H,9-11,13H2,(H,24,25);8*1H/t;16-;;19-;;;;;;;;/m.1.0......../s1
InChIKeyMDXAHCJGEHPMJY-UIDJTZLVSA-N
XLogP13.17
TPSA458.77 Ų
H-Bond Donors9
H-Bond Acceptors30
Rotatable Bonds31
Heavy Atoms137
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001995.50
LogP ≤ 513.17
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide?
The IUPAC name of (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide (CID 159538507) is (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide.
What is the SMILES notation for (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide?
The canonical SMILES for (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide is CC(=O)CC(C(=O)N1CCN(c2ccc(S(=O)(=O)Nc3ccncn3)cc2)CC1)c1ccccc1.CC(Nc1ccccc1NN)C(=O)N1CCN(c2ccc(S(=O)(=O)Nc3ccncn3)cc2)CC1.C[C@H](C(=O)NC1CCN(c2ccc(S(=O)(=O)Nc3ncns3)cc2)CC1)n1ccc2c(F)cccc21.O=C1[C@@H](NCCc2ccccc2F)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide?
The InChIKey is MDXAHCJGEHPMJY-UIDJTZLVSA-N. The full InChI is InChI=1S/C25H27N5O4S.C24H25FN6O3S2.C23H28N8O3S.C21H21FN4O3S2.8H2/c1-19(31)17-23(20-5-3-2-4-6-20)25(32)30-15-13-29(14-16-30)21-7-9-22(10-8-21)35(33,34)28-24-11-12-26-18-27-24;1-16(31-14-11-20-21(25)3-2-4-22(20)31)23(32)28-17-9-12-30(13-10-17)18-5-7-19(8-6-18)36(33,34)29-24-26-15-27-35-24;1-17(27-20-4-2-3-5-21(20)28-24)23(32)31-14-12-30(13-15-31)18-6-8-19(9-7-18)35(33,34)29-22-10-11-25-16-26-22;22-18-4-2-1-3-15(18)9-11-23-19-10-13-26(20(19)27)16-5-7-17(8-6-16)31(28,29)25-21-24-12-14-30-21;;;;;;;;/h2-12,18,23H,13-17H2,1H3,(H,26,27,28);2-8,11,14-17H,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29);2-11,16-17,27-28H,12-15,24H2,1H3,(H,25,26,29);1-8,12,14,19,23H,9-11,13H2,(H,24,25);8*1H/t;16-;;19-;;;;;;;;/m.1.0......../s1.
What are the key properties of (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide?
(2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide has a molecular weight of 1995.50 g/mol, XLogP of 13.17, 31 rotatable bonds, 9 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-(4-fluoroindol-1-yl)-N-[1-[4-(1,2,4-thiadiazol-5-ylsulfamoyl)phenyl]piperidin-4-yl]propanamide;4-[(3S)-3-[2-(2-fluorophenyl)ethylamino]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[2-(2-hydrazinylanilino)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen;4-[4-(4-oxo-2-phenylpentanoyl)piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide is sourced from PubChem (CID 159538507), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).